RNU7-93P

Across TCGA pan-cancer cohorts, RNU7-93P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNU7-93P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNU7-93P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU7-93P expression acts as an unfavorable survival marker.

BLCA, SARC, and LIHC are the cancer types where RNU7-93P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.162	0.618	<.001	63	view →
SARC	OS	Tertile	All	0.108	0.827	<.001	27	view →
LIHC	DFS	Tertile	All	0.155	0.555	.036	18	view →
THCA	DFS	Tertile	All	0.818	0.946	.035	3	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNU7-93P–BLCA (DFS)

Open the BLCA breakdown →